Protein biomarkers could allow early detection of ‘deadly’ dengue feverPosted: February 17, 2012
Researchers have developed the first precise predictive model to distinguish between dengue fever (DF) and its more severe form, dengue hemorrhagic fever (DHF).
The breakthrough by researchers at the University of Texas Medical Branch, could vastly reduce the disease’s mortality rate.
These studies could lead to a personalized approach to treatment of dengue fever.
“We have long known that dengue has many manifestations, from asymptomatic to a flu-like state to a life-threatening condition. If we could figure out early a patient’s susceptibility to the deadly form, we could save thousands of lives,” said lead author Dr. Allan Brasier, Director of UTMB’s Institute for Translational Sciences, with a multidisciplinary team of protein biochemists and bioinformatics specialists developing approaches to personalized medicine – work that will allow doctors to provide better individual diagnostics and treatments for common illnesses.